JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2021, Vol. 41 ›› Issue (2): 210-216.doi: 10.3969/j.issn.1674-8115.2021.02.013
• Clinical research • Previous Articles Next Articles
Qing LIU1(), Wen CAI2, Rui-qing ZHANG2, Cong LU2, Jia-rong ZHANG2,3(), Xian-ming XU2
Received:
2020-05-18
Online:
2021-02-28
Published:
2021-02-28
Contact:
Jia-rong ZHANG
E-mail:18101917515@163.com;maggie1974@126.com
Supported by:
CLC Number:
Qing LIU, Wen CAI, Rui-qing ZHANG, Cong LU, Jia-rong ZHANG, Xian-ming XU. Value of pregnancy lipid tolerance test in predicting risk of gestational diabetes mellitus[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 210-216.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2021.02.013
Item | Control group (n=49) | GDM group (n=22) | P value |
---|---|---|---|
Age/year | 30.6±3.9 | 31.5±4.9 | 0.113 |
Gravidity/n | 2.1±0.5 | 1.2±1.2 | 0.311 |
Parity/n | 0.5±0.5 | 0.6±0.7 | 0.576 |
Birth interval/year | 2.7±3.6 | 2.4±4.2 | 0.717 |
Prepregnancy BMI/(kg·m-2) | 21.3 (19.7?24.3) | 21.4 (20.8?24.5) | 0.094 |
Systolic blood pressure/mmHg | 114.1±8.9 | 113.4±8.8 | 0.333 |
Diastolic blood pressure/mmHg | 68.1±9.6 | 70.1±8.0 | 0.158 |
GPT/(U·L-1) | 16.4 (12.3?20.4) | 14.8 (11.6?19.4) | 0.907 |
GOT/(U·L-1) | 16.4 (13.6?18.2) | 15.2 (12.5?24.0) | 0.928 |
Tab 1 Comparison of general characteristics between the two groups
Item | Control group (n=49) | GDM group (n=22) | P value |
---|---|---|---|
Age/year | 30.6±3.9 | 31.5±4.9 | 0.113 |
Gravidity/n | 2.1±0.5 | 1.2±1.2 | 0.311 |
Parity/n | 0.5±0.5 | 0.6±0.7 | 0.576 |
Birth interval/year | 2.7±3.6 | 2.4±4.2 | 0.717 |
Prepregnancy BMI/(kg·m-2) | 21.3 (19.7?24.3) | 21.4 (20.8?24.5) | 0.094 |
Systolic blood pressure/mmHg | 114.1±8.9 | 113.4±8.8 | 0.333 |
Diastolic blood pressure/mmHg | 68.1±9.6 | 70.1±8.0 | 0.158 |
GPT/(U·L-1) | 16.4 (12.3?20.4) | 14.8 (11.6?19.4) | 0.907 |
GOT/(U·L-1) | 16.4 (13.6?18.2) | 15.2 (12.5?24.0) | 0.928 |
Variable | Fasting PG/(mmol·L-1) | 1 h PG/(mmol·L-1) | 2 h PG/(mmol·L-1) | HOMA-IR | ||||
---|---|---|---|---|---|---|---|---|
M(P25?P75) | P value | M(P25?P75) | P value | M(P25?P75) | P value | M(P25?P75) | P value | |
Fasting TAG | 0.005 | 0.087 | 0.112 | 0.003 | ||||
Low binary | 4.2 (4.2?4.8) | 7.7±1.6 | 7.0 (6.1?7.7) | 1.2 (0.8?1.4) | ||||
High binary | 4.8 (4.4?5.0) | 8.5±1.8 | 7.2 (6.4?8.1) | 1.7 (1.1?2.2) | ||||
2 h TAG | 0.000 | 0.004 | 0.058 | 0.009 | ||||
Low binary | 4.4 (4.2?7.6) | 7.6±1.4 | 7.0 (6.1?7.6) | 1.2 (0.8?1.6) | ||||
High binary | 4.9 (4.6?5.1) | 8.7±1.9 | 7.3 (6.4?7.9) | 1.5 (1.1?2.2) | ||||
4 h TAG | 0.000 | 0.016 | 0.078 | 0.020 | ||||
Low binary | 4.4 (4.2?4.7) | 7.7±1.4 | 7.0 (6.1?7.7) | 1.2 (0.9?1.6) | ||||
High binary | 4.9 (4.5?5.1) | 8.6±1.9 | 7.3 (6.3?8.0) | 1.5 (1.2?2.2) | ||||
Fasting FFA | 0.311 | 0.401 | 0.067 | 0.306 | ||||
Low binary | 4.7 (4.3?5.1) | 8.3±1.7 | 7.4 (6.6?7.9) | 1.4 (1.0?2.1) | ||||
High binary | 4.6 (4.3?4.8) | 8.0±1.8 | 7.0 (6.1?7.6) | 1.2 (0.9?1.7) | ||||
2 h FFA | 0.382 | 0.818 | 0.840 | 0.739 | ||||
Low binary | 4.7 (4.3?5.1) | 8.1±2.0 | 7.1 (6.3?7.7) | 1.3 (0.9?2.0) | ||||
High binary | 4.6 (4.4?4.8) | 8.1±1.5 | 7.1 (6.3?7.8) | 1.3 (1.0?1.8) | ||||
4 h FFA | 0.047 | 0.613 | 0.629 | 0.441 | ||||
Low binary | 4.5 (4.3?4.9) | 8.0±1.4 | 7.4 (6.6?7.7) | 1.2 (0.9?1.7) | ||||
High binary | 4.7 (4.5?5.0) | 8.3±2.0 | 6.9 (6.3?2.1) | 1.4 (1.0?2.1) | ||||
Fasting sd-LDL | 0.003 | 0.218 | 0.505 | 0.015 | ||||
Low binary | 4.4 (4.2?4.7) | 7.9±1.7 | 7.1 (6.0?7.8) | 1.2 (0.8?1.6) | ||||
High binary | 4.8 (4.4?5.0) | 8.4±1.7 | 7.2 (6.4?7.9) | 1.5 (1.1?2.2) | ||||
2 h sd-LDL | 0.002 | 0.178 | 0.490 | 0.011 | ||||
Low binary | 4.4 (4.2?4.7) | 7.8±1.7 | 7.1 (6.0?7.7) | 1.2 (0.8?1.5) | ||||
High binary | 4.9 (4.5?5.0) | 8.4±1.8 | 7.1 (6.3?7.9) | 1.6 (1.1?2.2) | ||||
4 h sd-LDL | 0.001 | 0.284 | 0.936 | 0.008 | ||||
Low binary | 4.4 (4.2?4.7) | 7.9±1.7 | 7.1 (6.1?7.8) | 1.1 (0.8?1.4) | ||||
High binary | 4.8 (4.5?5.0) | 8.4±1.7 | 7.2 (6.3?7.8) | 1.6 (1.2?2.1) |
Tab 2 Comparison of blood glucose and HOMA-IR in different OLTT groups
Variable | Fasting PG/(mmol·L-1) | 1 h PG/(mmol·L-1) | 2 h PG/(mmol·L-1) | HOMA-IR | ||||
---|---|---|---|---|---|---|---|---|
M(P25?P75) | P value | M(P25?P75) | P value | M(P25?P75) | P value | M(P25?P75) | P value | |
Fasting TAG | 0.005 | 0.087 | 0.112 | 0.003 | ||||
Low binary | 4.2 (4.2?4.8) | 7.7±1.6 | 7.0 (6.1?7.7) | 1.2 (0.8?1.4) | ||||
High binary | 4.8 (4.4?5.0) | 8.5±1.8 | 7.2 (6.4?8.1) | 1.7 (1.1?2.2) | ||||
2 h TAG | 0.000 | 0.004 | 0.058 | 0.009 | ||||
Low binary | 4.4 (4.2?7.6) | 7.6±1.4 | 7.0 (6.1?7.6) | 1.2 (0.8?1.6) | ||||
High binary | 4.9 (4.6?5.1) | 8.7±1.9 | 7.3 (6.4?7.9) | 1.5 (1.1?2.2) | ||||
4 h TAG | 0.000 | 0.016 | 0.078 | 0.020 | ||||
Low binary | 4.4 (4.2?4.7) | 7.7±1.4 | 7.0 (6.1?7.7) | 1.2 (0.9?1.6) | ||||
High binary | 4.9 (4.5?5.1) | 8.6±1.9 | 7.3 (6.3?8.0) | 1.5 (1.2?2.2) | ||||
Fasting FFA | 0.311 | 0.401 | 0.067 | 0.306 | ||||
Low binary | 4.7 (4.3?5.1) | 8.3±1.7 | 7.4 (6.6?7.9) | 1.4 (1.0?2.1) | ||||
High binary | 4.6 (4.3?4.8) | 8.0±1.8 | 7.0 (6.1?7.6) | 1.2 (0.9?1.7) | ||||
2 h FFA | 0.382 | 0.818 | 0.840 | 0.739 | ||||
Low binary | 4.7 (4.3?5.1) | 8.1±2.0 | 7.1 (6.3?7.7) | 1.3 (0.9?2.0) | ||||
High binary | 4.6 (4.4?4.8) | 8.1±1.5 | 7.1 (6.3?7.8) | 1.3 (1.0?1.8) | ||||
4 h FFA | 0.047 | 0.613 | 0.629 | 0.441 | ||||
Low binary | 4.5 (4.3?4.9) | 8.0±1.4 | 7.4 (6.6?7.7) | 1.2 (0.9?1.7) | ||||
High binary | 4.7 (4.5?5.0) | 8.3±2.0 | 6.9 (6.3?2.1) | 1.4 (1.0?2.1) | ||||
Fasting sd-LDL | 0.003 | 0.218 | 0.505 | 0.015 | ||||
Low binary | 4.4 (4.2?4.7) | 7.9±1.7 | 7.1 (6.0?7.8) | 1.2 (0.8?1.6) | ||||
High binary | 4.8 (4.4?5.0) | 8.4±1.7 | 7.2 (6.4?7.9) | 1.5 (1.1?2.2) | ||||
2 h sd-LDL | 0.002 | 0.178 | 0.490 | 0.011 | ||||
Low binary | 4.4 (4.2?4.7) | 7.8±1.7 | 7.1 (6.0?7.7) | 1.2 (0.8?1.5) | ||||
High binary | 4.9 (4.5?5.0) | 8.4±1.8 | 7.1 (6.3?7.9) | 1.6 (1.1?2.2) | ||||
4 h sd-LDL | 0.001 | 0.284 | 0.936 | 0.008 | ||||
Low binary | 4.4 (4.2?4.7) | 7.9±1.7 | 7.1 (6.1?7.8) | 1.1 (0.8?1.4) | ||||
High binary | 4.8 (4.5?5.0) | 8.4±1.7 | 7.2 (6.3?7.8) | 1.6 (1.2?2.1) |
Variable | GDM /n (%) | P value |
---|---|---|
Fasting TAG | 0.144 | |
Low binary | 8 (22.9) | |
High binary | 14 (38.9) | |
2 h TAG | 0.003 | |
Low binary | 5 (14.2) | |
High binary | 17 (47.2) | |
4 h TAG | 0.008 | |
Low binary | 6 (16.7) | |
High binary | 16 (45.7) | |
Fasting FFA | 0.311 | |
Low binary | 13 (37.1) | |
High binary | 9 (25.0) | |
2 h FFA | 0.382 | |
Low binary | 12 (34.3) | |
High binary | 10 (27.7) | |
4 h FFA | 0.047 | |
Low binary | 8 (22.8) | |
High binary | 14 (38.8) | |
Fasting sd-LDL | 0.003 | |
Low binary | 6 (17.1) | |
High binary | 16 (44.4) | |
2 h sd-LDL | 0.002 | |
Low binary | 6 (16.7) | |
High binary | 16 (45.7) | |
4 h sd-LDL | 0.001 | |
Low binary | 8 (22.8) | |
High binary | 14 (38.9) |
Tab 3 Comparison of incidence of GDM in pregnant women with different TAG, FFA and sd-LDL levels
Variable | GDM /n (%) | P value |
---|---|---|
Fasting TAG | 0.144 | |
Low binary | 8 (22.9) | |
High binary | 14 (38.9) | |
2 h TAG | 0.003 | |
Low binary | 5 (14.2) | |
High binary | 17 (47.2) | |
4 h TAG | 0.008 | |
Low binary | 6 (16.7) | |
High binary | 16 (45.7) | |
Fasting FFA | 0.311 | |
Low binary | 13 (37.1) | |
High binary | 9 (25.0) | |
2 h FFA | 0.382 | |
Low binary | 12 (34.3) | |
High binary | 10 (27.7) | |
4 h FFA | 0.047 | |
Low binary | 8 (22.8) | |
High binary | 14 (38.8) | |
Fasting sd-LDL | 0.003 | |
Low binary | 6 (17.1) | |
High binary | 16 (44.4) | |
2 h sd-LDL | 0.002 | |
Low binary | 6 (16.7) | |
High binary | 16 (45.7) | |
4 h sd-LDL | 0.001 | |
Low binary | 8 (22.8) | |
High binary | 14 (38.9) |
OLTT | AUC | Standard error | P value | Best diagnostic value | Sensitivity/% | Specificity/% | 95%CI(AUC) |
---|---|---|---|---|---|---|---|
Fasting TAG | 0.701 | 0.065 | 0.007 | 1.690 | 86.0 | 44.9 | 0.573?0.829 |
2 h TAG | 0.681 | 0.068 | 0.015 | 2.795 | 77.3 | 61.2 | 0.548?0.814 |
4 h TAG | 0.662 | 0.069 | 0.030 | 2.250 | 86.4 | 49.0 | 0.527?0.798 |
Fasting FFA | 0.494 | 0.077 | 0.941 | - | - | - | 0.343?0.645 |
2 h FFA | 0.487 | 0.070 | 0.857 | - | - | - | 0.350?0.623 |
4 h FFA | 0.670 | 0.068 | 0.023 | 0.915 | 54.5 | 79.6 | 0.537?0.802 |
Fasting sd-LDL | 0.701 | 0.069 | 0.007 | 28.555 | 86.4 | 49.0 | 0.565?0.837 |
2 h sd-LDL | 0.713 | 0.068 | 0.004 | 34.580 | 72.7 | 63.3 | 0.579?0.847 |
4 h sd-LDL | 0.702 | 0.069 | 0.007 | 44.730 | 50.0 | 85.7 | 0.567?0.838 |
Tab 4 Comparison of diagnostic efficiency of each index for GDM
OLTT | AUC | Standard error | P value | Best diagnostic value | Sensitivity/% | Specificity/% | 95%CI(AUC) |
---|---|---|---|---|---|---|---|
Fasting TAG | 0.701 | 0.065 | 0.007 | 1.690 | 86.0 | 44.9 | 0.573?0.829 |
2 h TAG | 0.681 | 0.068 | 0.015 | 2.795 | 77.3 | 61.2 | 0.548?0.814 |
4 h TAG | 0.662 | 0.069 | 0.030 | 2.250 | 86.4 | 49.0 | 0.527?0.798 |
Fasting FFA | 0.494 | 0.077 | 0.941 | - | - | - | 0.343?0.645 |
2 h FFA | 0.487 | 0.070 | 0.857 | - | - | - | 0.350?0.623 |
4 h FFA | 0.670 | 0.068 | 0.023 | 0.915 | 54.5 | 79.6 | 0.537?0.802 |
Fasting sd-LDL | 0.701 | 0.069 | 0.007 | 28.555 | 86.4 | 49.0 | 0.565?0.837 |
2 h sd-LDL | 0.713 | 0.068 | 0.004 | 34.580 | 72.7 | 63.3 | 0.579?0.847 |
4 h sd-LDL | 0.702 | 0.069 | 0.007 | 44.730 | 50.0 | 85.7 | 0.567?0.838 |
1 | Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type Ⅱ diabetes mellitus [J]. Diabetologia,2001, 44(8): 929-945. |
2 | Aslam M, Aggarwal S, Sharma KK, et al. Postprandial hypertriglyceridemia predicts development of insulin resistance glucose intolerance and type 2 diabetes[J]. PLoS One, 2016, 11(1): e0145730. |
3 | Morentin Gutierrez P, Yates J, Nilsson C, et al. Evolving data analysis of an oral lipid tolerance test toward the standard for the oral glucose tolerance test: cross species modeling effects of AZD7687 on plasma triacylglycerol[J]. Pharmacol Res Perspect, 2019, 7(2): e00465. |
4 | Patsch JR, Miesenböck G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state [J]. Arterioscler Thromb, 1992, 12(11): 1336-1345. |
5 | 窦攀, 张涵, 杨慧霞. 结合«中国居民膳食营养素参考摄入量(2013版)»和妊娠合并糖尿病相关指南解读妊娠期能量[J]. 中华围产医学杂志, 2015, 18(8): 582-585. |
6 | 杨慧霞, 徐先明, 王子莲,等. 妊娠合并糖尿病诊治指南(2014) [J]. 中华围产医学杂志, 2014, 17(8): 537-545. |
7 | Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women[J]. JAMA, 2007, 298(3): 299-308. |
8 | 田丰, 王亚婷, 刘玲. 非空腹血脂指标的临床应用[J]. 中华心血管病杂志, 2017, 45(2): 104-107. |
9 | Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction[J]. Circulation, 2008, 118(20): 2047-2056. |
10 | 熊芳, 王宗保, 唐朝克. 富含甘油三酯脂蛋白代谢及其在动脉粥样硬化中的作用 [J]. 中国动脉硬化杂志, 2019, 27(1): 81-86. |
11 | Adamska E, Ostrowska L, Gościk J, et al. Intake of meals containing high levels of carbohydrates or high levels of unsaturated fatty acids induces postprandial dysmetabolism in young overweight/obese men[J]. Biomed Res Int, 2015, 2015:147196. |
12 | van Hees AMJ, Saris WHM, Dallinga-Thie GM, et al. Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution[J]. J Nutr, 2008, 138(12): 2399-2405. |
13 | 郑媛媛, 翟桂荣. 妊娠与血脂代谢异常的探究[J]. 医学综述, 2013, 19(21): 3874-3876. |
14 | 宋庆雷, 李欣. 妊娠期糖尿病胰岛素抵抗与铁蛋白及游离脂肪酸的相关性研究[J]. 检验医学与临床, 2016, 13(3): 320-321, 324. |
15 | 彭峰, 林金秀, 曾开淇, 等. 胰岛素抵抗在肥胖患者餐后甘油三酯代谢中的作用[J]. 中华内科杂志, 2003, 42(9): 647-648. |
16 | 卞华, 高鑫. 非酒精性脂肪性肝病与2型糖尿病[J]. 中华糖尿病杂志, 2016, 8(9): 516-519. |
17 | 王莹, 白凤琴, 周尧. 妊娠期糖尿病患者血清胎球蛋白 A、胰岛素抵抗指数水平及其临床意义研究[J]. 中国妇幼保健, 2019, 34(9): 1986-1988. |
18 | Gentile M, Peluso R, di Minno MND, et al. Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis[J]. Clin Rheumatol, 2016, 35(8): 2023-2029. |
19 | Qiu C, Rudra C, Austin MA, et al. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size[J]. Physiol Res, 2007, 56(5): 571-578. |
20 | Ryckman KK, Spracklen CN, Smith CJ, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis[J]. BJOG, 2015, 122(5): 643-651. |
21 | Ghodke B, Pusukuru R, Mehta V. Association of lipid profile in pregnancy with preeclampsia, gestational diabetes mellitus, and preterm delivery[J]. Cureus, 2017, 9(7): e1420. |
22 | Vidakovic AJ, Jaddoe VW, Voortman T, et al. Maternal plasma polyunsaturated fatty acid levels during pregnancy and childhood lipid and insulin levels[J]. Nutr Metab Cardiovasc Dis, 2017, 27(1): 78-85. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||